arrow
M

Michelle Petri

Johns Hopkins University
H指数:136
被引数:7.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Bias due to interval censored outcomes in a study of flare risk after hydroxychloroquine taper/cessation in systemic lupus erythematosus

系统性红斑狼疮患者羟氯喹减量/停药后 flare 风险研究中区间删失结局导致的偏倚

2026-03-300
PRE
Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step Toward Precision Drug Monitoring

定义羟氯喹在狼疮中最佳安全有效的血药浓度:迈向精准药物监测的重要一步

2026-02-013
OAAI
Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countries

抗磷脂综合征的心血管风险因素控制,以及原发性抗磷脂综合征与系统性红斑狼疮相关抗磷脂综合征(SURF-SLE和APS项目)之间的差异:一项来自11个国家1003例个体的横断面研究

2025-11-190
PRE
A human-mouse atlas of intrarenal myeloid cells identifies conserved disease-associated macrophages in lupus nephritis

人类-小鼠肾脏内髓系细胞图谱鉴定了狼疮肾炎中保守的疾病相关巨噬细胞

2025-09-031
PRE
ERN ReCONNET–SLICC–SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations

ERN ReCONNET–SLICC–SLEuro专家共识:罕见系统性红斑狼疮表现的药物治疗管理

2025-05-230
PRE
Direct oral anticoagulants versus Vitamin K antagonists in antiphospholipid syndrome: A systematic review and meta-analysis

直接口服抗凝剂与维生素K拮抗剂在抗磷脂综合征中的比较:一项系统评价和荟萃分析

2025-05-010
OAAI
Patients achieving low lupus disease activity state, systemic lupus erythematosus disease control or remission showed lower rates of organ damage during longitudinal follow-up: analysis of the Hopkins Lupus Cohort

达到低狼疮疾病活动状态,系统性红斑狼疮疾病控制或缓解的患者在纵向随访期间显示较低的器官损伤发生率: 霍普金斯狼疮队列分析

2024-12-110
OAAI
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-D Report: Multicriteria Decision Analysis
2024-09-301
OA